Latest news
Cytokinetics (CYTK) Stock Looks Near Fair Value Despite UK MYQORZO Approval - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 11:10:15 GMTCYTK Q2 Earnings Top Estimates, Myqorzo Uptake Strong - TradingViewTradingView · Fri, 07 Aug 2026 18:22:00 GMTHow Investors May Respond To Cytokinetics (CYTK) UK MYQORZO Approval Amid Wider Quarterly Loss - simplywall.stsimplywall.st · Fri, 07 Aug 2026 08:30:16 GMTCytokinetics Reports Second Quarter 2026 Financial Results and Provides Business Update - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 20:13:57 GMTCytokinetics' aficamten trial met both primary endpoints; Q4 filing expected - Stock TitanStock Titan · Thu, 06 Aug 2026 20:00:00 GMTUK approves myqorzo for rare heart disease - Minute MirrorMinute Mirror · Fri, 31 Jul 2026 15:13:05 GMTNICE & MHRA Accelerate Access to Cytokinetics' Myqorzo for Obstructive HCM - NAVLIN DAILYNAVLIN DAILY · Fri, 31 Jul 2026 09:18:48 GMTMyqorzo: UK approves pill for serious heart condition - ARYnews.tvARYnews.tv · Thu, 30 Jul 2026 16:41:49 GMT